FIBRINOGEN AS A RISK FACTOR FOR STROKE AND MYOCARDIAL-INFARCTION

被引：1636
作者：
WILHELMSEN, L
SVARDSUDD, K
KORSANBENGTSEN, K
LARSSON, B
WELIN, L
TIBBLIN, G
机构：
[1] SAHLGRENS HOSP,DEPT MED,S-41345 GOTHENBURG,SWEDEN
[2] GOTHENBURG UNIV,S-41124 GOTHENBURG,SWEDEN
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1984年 / 311卷 / 08期
关键词：
D O I：
10.1056/NEJM198408233110804
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：501 / 505
页数：5
相关论文
共 23 条
[1]  
[Anonymous], 1978, N ENGL J MED, V299, P53
[2]   DETERMINATION OF PLASMINOGEN IN HUMAN PLASMA BY LYSIS TIME METHOD [J].
BERG, W ;
KORSANBE.K ;
YGGE, J .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1966, 16 (1-2) :1-&
[3]  
BLOMBACK B, 1958, ARK KEMI, V12, P99
[4]   PHYSIOLOGICAL MECHANISMS IN COAGULATION AND FIBRINOLYSIS [J].
BROZOVIC, M .
BRITISH MEDICAL BULLETIN, 1977, 33 (03) :231-238
[5]  
ELMFELDT D, 1975, ACTA MED SCAND, V197, P497
[6]   CONTROLLED TRIAL OF ASPIRIN IN CEREBRAL ISCHEMIA [J].
FIELDS, WS ;
LEMAK, NA ;
FRANKOWSKI, RF ;
HARDY, RJ .
STROKE, 1977, 8 (03) :301-316
[7]   CONTROLLED TRIAL OF ASPIRIN IN CEREBRAL ISCHEMIA .2. SURGICAL GROUP [J].
FIELDS, WS ;
LEMAK, NA ;
FRANKOWSKI, RF ;
HARDY, RJ .
STROKE, 1978, 9 (04) :309-319
[8]  
HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215
[9]  
HARMSEN P, 1979, ACTA MED SCAND, V206, P337
[10]   BLOOD-COAGULATION AND FIBRINOLYSIS IN MAN AFTER MYOCARDIAL-INFARCTION COMPARED WITH A REPRESENTATIVE POPULATION SAMPLE [J].
KORSANBE.K ;
WILHELMS.L ;
TIBBLIN, G ;
ELMFELDT, D .
ATHEROSCLEROSIS, 1972, 16 (01) :83-&
123